Evaluating the Safety of Immediate Versus Deferred Isoniazid Preventive Therapy Among HIV-Infected Pregnant Women

NCT01494038 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

956

Enrollment

NIH

Sponsor class

Conditions

HIV Infections
Tuberculosis

Interventions

DRUG: Isoniazid (INH)
DRUG: Placebo for isoniazid (INH)

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)